SANTYL

This brand name is authorized in Canada, United States

Active ingredients

The drug SANTYL contains one active pharmaceutical ingredient (API):

1 Collagenase
UNII 9X7O8V25IT - COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

Collagenases are proteinases that hydrolyze collagen under physiological conditions. Collagenase clostridium histolyticum is comprised of a mixture of Class I (AUX-I) and Class II (AUX-II) clostridial collagenases in a defined mass ratio. Both collagenases effectively cleave interstitial collagen but at different sites on the molecule; additionally, they prefer different conformations (triple helical versus denatured or cleaved).

Read about Collagenase

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
COLLAGENASE SANTYL Ointment FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D03BA02 Clostridiopeptidase D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03B Enzymes → D03BA Proteolytic enzymes
Discover more medicines within D03BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02063670
Country: US FDA, National Drug Code Identifier(s): 50484-010

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.